Abstract
Importance Some studies suggest that social media use is associated with risk for depression, particularly among children and young adults.
Objective To characterize the association between self-reported use of individual social media platforms, and worsening of depressive symptoms, among adults.
Design We included data from 13 waves of a non-probability internet survey conducted between May 2020 and May 2021 among individuals age 18 and older in the United States. We applied logistic regression with 5 or more point increase in PHQ-9 as outcome, and sociodemographic features, baseline PHQ-9, and use of each social media platform as independent variables, without reweighting.
Participants Survey respondents 18 and older.
Main Outcome and Measure PHQ-9 worsening by 5 points or more.
Results A total of 5395/8045 (67.1%) individuals with a PHQ-9<5 on initial survey completed a second PHQ-9. These respondents had mean age 55.82 years (SD 15.17); 3546 (65.7%) reported female gender, the remainder male; 329 (6.1%) were Asian, 570 (10.6%) Black, 256 (4.7%) Hispanic, 4118 (76.3%) White, and 122 (2.3%) Native American or Alaska Native, Pacific Islander or Native Hawaiian, or Other. Among them, 482 (8.9%) reported 5 point or greater worsening at second survey. In fully-adjusted models for increase in symptoms, largest odds ratio associated with social media use was observed for Snapchat (aOR 1.53, 95% CI 1.19-1.96), Facebook (aOR 1.42, 1.10-1.81), and TikTok (aOR 1.39, 95% CI 1.03-1.87).
Conclusions and Relevance Among survey respondents who did not report depressive symptoms initially, social media use was associated with greater likelihood of subsequent increase in depressive symptoms after adjustment for sociodemographic features and news sources. These data cannot elucidate the nature of this relationship, but suggest the need for further study to understand the impact of social media use.
Trial Registration NA
Competing Interest Statement
Dr. Perlis has received consulting fees from Belle Artificial Intelligence, Burrage Capital, Genomind, RID Ventures, and Takeda. He holds equity in Psy Therapeutics. The other authors report no disclosures.
Funding Statement
This study was supported by the National Science Foundation (SES-2029292 and SES-2029792; Drs. Baum, Lazer, Druckman, and Ognyanova). Dr. Perlis is supported by the National Institute of Mental Health (R01MH116270; Dr. Perlis). The sponsors did not contribute to design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Dr. Perlis had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Institutional Review Board of Harvard University, and participants provided informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are not available for distribution.
